S88517 |
SRI 31215 TFA |
源葉(MedMol) | 98% |
- 產(chǎn)品描述: SRI 31215 (TFA) is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer[1]
- 靶點(diǎn): IC50: 0.69 μM (matriptase); 0.65 μM (hepsin); 0.30 μM (HGFA);c-Met/HGFR
- 參考文獻(xiàn):
1. Owusu BY, et al. Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling. Oncotarget. 2016 May 17;7(20):29492-506.
- 溶解性: Soluble in DMSO
- 保存條件: -20°C
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 1.874 ml 9.37 ml 18.741 ml 5 mM 0.375 ml 1.874 ml 3.748 ml 10 mM 0.187 ml 0.937 ml 1.874 ml 50 mM 0.037 ml 0.187 ml 0.375 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):
本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)